ATE508364T1 - Diagnoseverfahren für präeklampsie - Google Patents

Diagnoseverfahren für präeklampsie

Info

Publication number
ATE508364T1
ATE508364T1 AT06837479T AT06837479T ATE508364T1 AT E508364 T1 ATE508364 T1 AT E508364T1 AT 06837479 T AT06837479 T AT 06837479T AT 06837479 T AT06837479 T AT 06837479T AT E508364 T1 ATE508364 T1 AT E508364T1
Authority
AT
Austria
Prior art keywords
sbp
preeclampsia
proteinaceous
sflt
plgf
Prior art date
Application number
AT06837479T
Other languages
English (en)
Inventor
David Sogin
Donald Laird
Zhiguang Yu
Robert Doss
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37820640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE508364(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE508364T1 publication Critical patent/ATE508364T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
AT06837479T 2005-11-14 2006-11-14 Diagnoseverfahren für präeklampsie ATE508364T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73665905P 2005-11-14 2005-11-14
US11/367,126 US20070111326A1 (en) 2005-11-14 2006-03-03 Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
PCT/US2006/044059 WO2007059065A2 (en) 2005-11-14 2006-11-14 Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia

Publications (1)

Publication Number Publication Date
ATE508364T1 true ATE508364T1 (de) 2011-05-15

Family

ID=37820640

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06837479T ATE508364T1 (de) 2005-11-14 2006-11-14 Diagnoseverfahren für präeklampsie

Country Status (8)

Country Link
US (1) US20070111326A1 (de)
EP (1) EP1952156B1 (de)
JP (1) JP5225097B2 (de)
AT (1) ATE508364T1 (de)
CA (1) CA2629451A1 (de)
DE (1) DE602006021777D1 (de)
ES (1) ES2363609T3 (de)
WO (1) WO2007059065A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005022047A1 (de) * 2005-05-09 2006-11-30 Dade Behring Marburg Gmbh Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung
US20080071151A1 (en) * 2006-06-30 2008-03-20 Sogin David C Method and Apparatus for Diagnosing Pre-eclampsia
DE602006015964D1 (de) * 2006-09-20 2010-09-16 Roche Diagnostics Gmbh Natriurethische Peptide und Plazenta-Wachstumfaktor/löslicher VEGF-Rezeptor unterscheiden zwischen mit der Plazenta verbundener Herzdysfunktion und mit Herzerkrankung verbundener Herzdysfunktion
DE102007038730A1 (de) * 2007-08-16 2009-02-19 Carl Zeiss Meditec Ag Nachweis des menschlichen Vascular Endothelial Growth Factor
WO2009089271A1 (en) 2008-01-07 2009-07-16 Ortho-Clinical Diagnostics, Inc. Calibrator/control for simultaneous assay of proteins capable of complexing with one another
RU2010133157A (ru) 2008-01-07 2012-02-20 Орто-Клиникал Дайэгностикс, Инк. (Us) Определение комплекса sflt-1:ангиогенный фактор
US8741287B2 (en) 2008-06-18 2014-06-03 Abbott Laboratories PlGF-1 assay and kits and components thereof
US20100004306A1 (en) * 2008-06-18 2010-01-07 Abbott Laboratories PIGF-1 Assay and kits and components thereof
AU2009316392B2 (en) * 2008-11-20 2015-05-21 Perkinelmer Health Sciences, Inc. Method for determining the risk of preeclampsia using PIGF-2 and PIGF-3 markers
US20100330703A1 (en) * 2009-06-24 2010-12-30 Seventh Sense Biosystems, Inc. Assays involving colorimetric and other signaling
CN103917875B (zh) 2011-11-09 2016-11-09 霍夫曼-拉罗奇有限公司 SFlt-1或Endoglin/PlGF的比例动态用作危急的先兆子痫和/或HELLP综合征的指示物
KR101996123B1 (ko) 2012-06-27 2019-07-03 에프. 호프만-라 로슈 아게 특정 시기 내에 임신중독증의 개시를 배제하기 위한 sFlt-1/PlGF 또는 엔도글린/PlGF 비의 적용 수단 및 방법
CN115015552A (zh) 2015-06-19 2022-09-06 赛拉预测公司 用于预测早产的生物标志物对
WO2017148854A1 (en) 2016-02-29 2017-09-08 Roche Diagnostics Gmbh Igfbp-7 as a marker in preeclampsia
CA3073192A1 (en) 2017-08-18 2019-02-21 Sera Prognostics, Inc Pregnancy clock proteins for predicting due date and time to birth
AU2018331400A1 (en) 2017-09-13 2020-04-02 Progenity, Inc. Preeclampsia biomarkers and related systems and methods
EP4070113A4 (de) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0114528A3 (de) * 1982-12-27 1986-05-14 Trustees Of Boston University Abscheidung von Zellen auf Platten unter Verwendung von Nicht-Antikörperliganden
AU614935B2 (en) * 1986-08-06 1991-09-19 Multilyte Limited Determination of analyte concentration using two labelling markers
AU742779B2 (en) * 1996-12-20 2002-01-10 Licentia Oy VEGF-B/receptor complex and uses thereof
WO2000026674A1 (en) * 1998-10-30 2000-05-11 Merska B.V. Screening for analytes using labeled receptors
ES2433011T3 (es) * 1999-12-20 2013-12-05 Immunex Corporation Receptor TWEAK
WO2002099421A2 (en) * 2001-05-18 2002-12-12 Thomas Jefferson University Specific microarrays for breast cancer screening
CN1332978C (zh) * 2001-09-12 2007-08-22 北京市肿瘤防治研究所 作为VEGF受体Flt－1拮抗剂的肽
US20050095646A1 (en) * 2001-11-19 2005-05-05 Sherman Michael I. Method of using a non-antibody protein to detect and measure an analyte
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
ES2534926T3 (es) * 2002-07-19 2015-04-30 Beth Israel Deaconess Medical Center Métodos para tratar la preeclampsia
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
US7344892B2 (en) * 2003-09-23 2008-03-18 Beth Israel Deaconess Medical Center, Inc. Screening for gestational disorders
EP1530047A1 (de) * 2003-11-07 2005-05-11 Roche Diagnostics GmbH Proximale Markermoleküle der Arterienthrombose und der Entzündung zur Risikostratifizierung einer koronaren Herzkrankheit
EP1615035B1 (de) * 2004-07-07 2007-06-06 F.Hoffmann-La Roche Ag Kombinationen von Markern zum Nachweis von typ 1 und 2 Diabetes
WO2006069373A2 (en) * 2004-12-21 2006-06-29 Yale University Diagnosis of preeclampsia

Also Published As

Publication number Publication date
EP1952156A2 (de) 2008-08-06
WO2007059065B1 (en) 2007-09-13
WO2007059065A2 (en) 2007-05-24
ES2363609T3 (es) 2011-08-10
JP5225097B2 (ja) 2013-07-03
US20070111326A1 (en) 2007-05-17
CA2629451A1 (en) 2007-05-24
DE602006021777D1 (de) 2011-06-16
JP2009516170A (ja) 2009-04-16
WO2007059065A3 (en) 2007-07-26
EP1952156B1 (de) 2011-05-04

Similar Documents

Publication Publication Date Title
ATE508364T1 (de) Diagnoseverfahren für präeklampsie
MX2007014815A (es) Metodos de inmunoanalisis mejorados.
SG169395A1 (en) Detection of cancer by elevated levels of bcl-2
TW200613729A (en) Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same
SG111139A1 (en) Mediator stabilized reagent compositions and methods for their use in electrochemical analyte detection assays
JP2011522272A5 (de)
WO2009152607A8 (en) Methods and kits for diagnosing neurodegenerative disease
MX2009006205A (es) Inmunoensayo de multiples analitos.
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
BRPI0812875A2 (pt) " método pra identificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, anticorpo específico para proteína ligante de heparina, método pra reduzir o risco de um indivíduo desenvolver sépsis severa, e, kit de teste ".
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
ATE395812T1 (de) Methoden zur vorhersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests
DE602007007775D1 (de) Reagenz für hämoglobinabbau
PL1977244T3 (pl) Rozróżnianie bakteryjnego i wirusowego zapalenia opon mózgowych
BRPI0618435A2 (pt) composição reagente de sensor teste tendo polìmeros de celulose adaptada para auxiliar na determinação de uma concentração de analito de uma amostra fluida, bem como processo de determinação de uma concentração de analito de uma amostra fluida
PE20120592A1 (es) Metodo con biomarcadores para el seguimiento de un tratamiento
CA2586654A1 (en) Use of asc as a marker for colorectal cancer
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
ATE420364T1 (de) Verfahren zur magenkrebsvorhersage
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
WO2008035204A3 (en) Prediction and prophylactic treatment of type 1 diabetes
ATE549417T1 (de) Diagnoseverfahren für osteoarthritis
Slocombe et al. A method for determining the concentration of haptoglobin in cattle blood following haemolysis caused at collection
DE602004026869D1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers
WO2022229421A3 (en) Strem1 marker panels for early detection of sepsis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties